✦ LIBER ✦

Protein tyrosine kinase inhibitors: new treatment modalities?

✍ Scribed by Doriano Fabbro; David Parkinson; Alex Matter

Book ID: 117786545
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 85 KB
Volume: 2
Category: Article
ISSN: 1471-4892
DOI: 10.1016/s1471-4892(02)00179-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protein Kinase Inhibitors: The Tyrosine-

Protein Kinase Inhibitors: The Tyrosine-Specific Protein Kinases

✍ David S. Lawrence; Jinkui Niu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Inhibitors of protein tyrosine kinases

✍ David W Fry; Alexander J Bridges 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 745 KB

The description in the past year of several novel protein tyrosine kinase inhibitors, which exhibit dramatic improvements in potency and specificity over earlier agents, will be considered a major turning point in the field. These compounds appear to have the necessary pharmacological properties to

Protein Kinase Inhibitors as a Therapeut

Protein Kinase Inhibitors as a Therapeutic Modality

✍ Alexander Levitzki 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 50 KB 👁 2 views

New tyrosine kinase inhibitor shows prom

New tyrosine kinase inhibitor shows promise

✍ Claudia Orellana 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 63 KB

Tyrosine kinase inhibitors and gemcitabi

Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer?

✍ Axel Kleespies; Karl-Walter Jauch; Christiane J. Bruns 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Development of inhibitors for protein ty

Development of inhibitors for protein tyrosine kinases

✍ Al-Obeidi, Fahad A; Lam, Kit S 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 260 KB